Last reviewed · How we verify

NCT03209076: RAR

Robotic Versus Laparoscopic Low Anterior Resection for Rectal Cancer

Status unknown NA Last updated 16 October 2019
What this trial tests

NA trial testing Robotic in Rectal Neoplasms in 120 participants. Status unknown.

Timeline
1 February 2018
Primary endpoint
1 June 2020
1 December 2020

Quick facts

Lead sponsorInstituto Nacional de Cancer, Brazil
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment120
Start date1 February 2018
Primary completion1 June 2020
Estimated completion1 December 2020
Sites1 location across Brazil

Drugs / interventions tested

Conditions studied

Sponsor

Instituto Nacional de Cancer, Brazil — full company profile →

Who can join

Adults 18 to 70, any sex, with Rectal Neoplasms or Sexual Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Prospective randomized trial comparing robotic versus laparoscopic Low anterior resection for rectal cancer. Primary endpoint: Compare urinary dysfunction between robotic and laparoscopic approach.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Robotic

Trials testing the same drug.

Other recruiting trials for Rectal Neoplasms

Currently open trials in the same condition.

Other Instituto Nacional de Cancer, Brazil trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03209076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing